Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Court allows ED to...

    Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case

    GarimaWritten by Garima Published On 2019-03-25T12:25:32+05:30  |  Updated On 25 March 2019 12:25 PM IST
    Court allows ED to seek assistance from 21 countries in Sterling Biotech bank fraud case

    New Delhi: A Delhi court has allowed the Enforcement Directorate to send letters rogatory (LR) to 21 countries, involving the UK and the UAE, seeking assistance in the probe of an Rs 8,100 crore bank fraud case involving Gujarat-based Sterling Biotech Ltd.


    Additional Sessions Judge Satish Kumar Arora granted permission to the agency on its plea seeking nod to send the LRs, also known as a letter of request, to countries, also involving the US, China, Panama and Austria.


    The LRs will also be send to Albania, where the court recently allowed the ED to send extradition requests after its special public prosecutor Nitesh Rana informed that its two directors -- Nitin Sandesara and Chetankumar Sandesara -- have obtained the citizenship.


    Another director of the firm, Hitesh Narender Bhai Patel, was detained in Albania's capital Tirana on March 20 on the basis of an Interpol notice issued against him by the ED.


    The application moved by ED's advocate A R Aditya also sought to send the LRs in some other countries which included Singapore, Switzerland, Hong Kong, Indonesia, Barbados, Bermuda, British Virgin Islands, Cyprus, Comoros, Jersey, Lichtenstein, Mauritius, Nigeria and Seychelles.


    It is alleged that the company took loans of over Rs 5,000 crore from a consortium led by Andhra Bank, which had turned into non-performing assets. The total volume of the alleged loan defraud is pegged at Rs 8,100 crore.


    Read Also: Banks agree to one time settlement with Sterling Biotech with 65 percent haircut


    The ED registered its case based on Central Bureau of Investigation charge sheet and is probing money laundering.


    The accused are also being probed by the ED for allegedly bribing senior Income Tax department officials as part of an earlier criminal complaint.


    The agency has filed five charge sheets in this case till now and attached properties valued at Rs 4,710 crore.


    Read also: Sterling Biotech: Accused in Rs 8100 crore loan fraud held in Albania

    allegedlyChetankumar Jayantilal SandesaraDelhi CourtDipti Chetan SandesaraEDEnforcement DirectorateFIRfraudHiteshkumar Narendrabhai Patel.Money LaunderingNBWNitin Jayantilal SandesaraPharmaceutical industryPMLAPrevention of Money Laundering ActRCNRed Corner NoticeSBLSBL promotersSterling BiotechSterling Biotech GroupSterling Biotech LtSterling Biotech Ltd
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok